C, A., I, P., M, L., M, G., R, C., B, A., . . . M, F. (2025). NRN1 genetic variability and methylation changes as biomarkers for cognitive remediation therapy response in schizophrenia. Progress in neuro-psychopharmacology & biological psychiatry, 136, 111175. https://doi.org/10.1016/j.pnpbp.2024.111175
Chicago Style (17th ed.) CitationC, Almodóvar-Payá, París-Gómez I, Latorre-Guardia M, Guardiola-Ripoll M, Catalán R, Arias B, Penadés R, and Fatjó-Vilas M. "NRN1 Genetic Variability and Methylation Changes as Biomarkers for Cognitive Remediation Therapy Response in Schizophrenia." Progress in Neuro-psychopharmacology & Biological Psychiatry 136 (2025): 111175. https://doi.org/10.1016/j.pnpbp.2024.111175.
MLA (9th ed.) CitationC, Almodóvar-Payá, et al. "NRN1 Genetic Variability and Methylation Changes as Biomarkers for Cognitive Remediation Therapy Response in Schizophrenia." Progress in Neuro-psychopharmacology & Biological Psychiatry, vol. 136, 2025, p. 111175, https://doi.org/10.1016/j.pnpbp.2024.111175.